NRx Pharmaceuticals (NRXP) Reports In-Line Q1 EPS

NRx Pharmaceuticals (NASDAQ: NRXP) reported Q1 EPS of $0.00. Revenue for the quarter came in at $1.07 million.

For earnings history and earnings-related data on NRx Pharmaceuticals (NRXP) click here.

You May Also Be Interested In

• eToro Group (ETOR) Reiterated at Market Outperform by Citizens as EBITDA Rises 9%
• JPMorgan Upgrades Multi Commodity Exchange of India Ltd (MCX:IN) to Overweight
• Aardvark Therapeutics (AARD) Tops Q2 EPS by 21c